Research &


Become a clinical partner or support our research, contact:

Clinicial investigation 


Our treatment has evolved from research and development with world leading institutions and centres. 



our partners

at a glance

We are trialling our treatment in the United Kingdom's top GP practices for patients presenting with depression in primary care.

Together with a leading Tinnitus research centre in Helsinki, Finland, we have run successful trials and developed a combined treatment of tVNS and Sound Therapy for chronic Tinnitus.

We are working with the world's leading cardiac research centre to conduct the first non-invasive vagus nerve stimulation clinical trial in patients with Atrial Fibrillation


Non-invasive Vagus Nerve Stimulation as a novel treatment method for cases of depression in primary care. 


Transcutaneous (Non-invasive) Vagus Nerve Stimulation to suppress Atrial Fibrillation.


Transcutaneous Vagus Nerve Stimulation (tVNS) as an intervention for Heart Failure.


Non-invasive Vagus Nerve Stimulation as a novel treatment method for Lupus; (SLE) Systemic Lupus Erythematosus.


Transcutaneous Vagus Nerve Stimulation (tVNS) and combined Sound Therapy (ST) in the treatment of chronic Tinnitus.


Transcutaneous Vagus Nerve Stimulation (tVNS) for the purposes of correcting autonomic dysfunction. 


Join us 




Helsinki Ear Institute

MSD Pharmaceutical

The University of Oklahoma Health Sciences Centre

Stow Heath

University Campus Suffolk

Canterbury Christchurch University

National Institute of Mental Health and Neuroscience

The Royal Free Hospital London